C. difficile spores are highly resistant to desiccation, chemicals and extreme temperature. Spores frequently contaminate the environment around patients with CDI, potentially persisting for ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Expert Rev Anti Infect Ther. 2010;8(10):1113-1119.

Swiss food giant Nestlé has said it wants to take full ownership of Seres Therapeutics’ Vowst microbiome therapy for Clostridiodes difficile infections (CDI), upgrading its current co-marketing ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

Treatment options will also differ by type of dacryocystitis. Antibiotics are prescribed for some cases of acute dacryocystitis. Oral antibiotics can treat the condition quickly. A severe infection ...

Here’s our process. If you’re managing a sexually transmitted infection (STI), you have options for treatment. While you can visit a healthcare professional in person for an evaluation and ...